BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 19564073)

  • 1. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
    He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
    Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y; He L; He G; Kong Y; Liu X; Cai H; Liu X; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):780-8. PubMed ID: 20815258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
    Zhang Y; Ma H; Zhang J; Liu S; Liu Y; Zheng D
    Life Sci; 2008 Jun; 82(23-24):1154-61. PubMed ID: 18485417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
    Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
    Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
    Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific antitumor effect of adeno-associated virus vector carrying TRAIL gene under the control of hTERT promoter].
    Qi R; Cai Y; Li BH; Lin ZX; Gu JF
    Ai Zheng; 2008 Oct; 27(10):1026-33. PubMed ID: 18851780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
    Gu J; Andreeff M; Roth JA; Fang B
    Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
    Irving J; Wang Z; Powell S; O'Sullivan C; Mok M; Murphy B; Cardoza L; Lebkowski JS; Majumdar AS
    Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
    You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
    Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enhanced transduction efficiency of adeno-associated virus on cancer cells with the help of low dose adenovirus].
    Li HM; Wang F; Wei F; Dong XY; Wang HP; Qiu W; Zhang JF; Chen XF; Wu XB; Huang Q
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1987-90. PubMed ID: 17923042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
    Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter.
    Liu J; Zou WG; Lang MF; Luo J; Sun LY; Wang XN; Qian QJ; Liu XY
    Int J Oncol; 2002 Sep; 21(3):661-6. PubMed ID: 12168115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells.
    Edqvist A; Rebetz J; Järås M; Rydelius A; Skagerberg G; Salford LG; Widegren B; Fan X
    Mol Ther; 2006 Jul; 14(1):139-48. PubMed ID: 16584924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.